Peterson Katharine sold ACRV
February 14, 2025 · Form 4 insider transaction
Peterson Katharine sold 116 shares of Acrivon Therapeutics, Inc. at $5.42 per share, a transaction worth $628.72. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
116
Price
$5.42
Total value
$628.72
InsiderPeterson Katharine
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 14, 2025
Filing dateFebruary 19, 2025
Shares owned after4,419
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.